DZDevran F. Zeinalov

Devran F. Zeinalov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Devran F. Zeinalov has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Alexander G. Edemskiy

    Meshalkin National Medical Research Center

    3 shared publications
  • Alexander Mikhailovich Chernyavskii

    National Medical Research Center named after Academician E.N. Meshalkin; Novosibirsk State Medical University

    3 shared publications
  • Denis S. Grankin

    Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации, Новосибирск

    3 shared publications
  • Oksana Ya. Vasiltseva

    Meshalkin National Medical Research Center

    3 shared publications
  • Dmitry Andreevich Sirota

    Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина» Министерства здравоохранения Российской Федерации; Федеральное государственное бюджетное образовательное учреждение высшего образования «Новосибирский государственный медицинский университет» Министерства здравоохранения Российской Федерации

    2 shared publications
  • Elena N. Kliver

    Meshalkin National Medical Research Center Moscow Russia

    2 shared publications

Latest Publications

  • Open Access

    Bioengineering generation of heart rhythm: the role of biopacemaker cells

    by V. V. Shabanov, E. V. Kosenko, D. F. Zeinalov, T. U. Khalkhozhaev, D. S. Sergeyevichev, A. G. Filippenko, A. B. Romanov, В. В. Шабанов, Э. В. Косенко, Д. Ф. Зейналов, et al.

    This review summarizes the anatomical and physiological characteristics of the sinoatrial node as a model for bio­ pacemakers and analyzes current approaches to their development, including sinoatrial node cell transplantation, the use of pluripotent stem cells, gene therapy (HCN overexpression, IK1 suppression, TBX18 transduction, and others), as well as combined and reprogramming strategies Special attention is given to the authors’ own experience and achievements in tissue engineering. Key obstacles to clinical translation are outlined, including safety concerns, stability of therapeutic effects, adequacy of experimental models, and control of biological pacemaker activity. Despite existing limitations, pro­ gress in gene engineering, stem cell technologies, and biomaterials offers promising opportunities for the development of fully physiological alternatives to electronic pacemakers.

  • Open Access

    Predictors of the development of residual pulmonary hypertension in patients with chronic thromboembolic pulmonary hypertension

    by Oksana Ya. Vasiltseva, Devran F. Zeinalov, Alexander G. Edemskiy, Алексей Геннадьевич Лавров, Денис Сергеевич Гранкин, Дмитрий Андреевич Сирота, Aleksandr M. Chernyavskiy

    Introduction. After pulmonary endarterectomy (PEA), a third of patients with chronic thromboembolic pulmonary hypertension (CTEPH) develop residual pulmonary hypertension (PH) in the postoperative period, which plays a decisive role in the formation of long-term mortality, but in modern clinical practice there are no tools for predicting its probability. Objective. of the study was to determine predictors of residual pulmonary hypertension after pulmonary endarterectomy. Methods. The retrospective cohort observational study included 353 patients aged 19 to 77 years with CTEPH who underwent PEA at the Federal State Budgetary Institution "National Medical Research Center named after Academician E.N. Meshalkin" from 2004 to 2019. The patients underwent clinical and instrumental examination before PEA, after PEA during the hospital period and in the late period (12 months) after PEA. An analysis of the obtained factors was carried out, non-modifiable and modifiable predictors of residual PH were determined. Results. According to the regression analysis, independent non-modifiable predictors of residual PH after PEA were identified: history of cancer; blood group AB (IV); reperfusion syndrome after PEA; pulmonary vascular resistance >1000 dyn×s×cm–5 according to pulmonary circulation tensiometry data before PEA; the ratio of the systolic excursion of the tricuspid valve annulus to the systolic pressure in the pulmonary artery 50 mmHg after PEA, measured by transthoracic echocardiography during the hospital period; thrombus calcification in the biopsy material of thrombotic masses. In addition, modifiable predictors were identified - delay in diagnosis and treatment of 6 months or more; obesity; smoking; anemia; irregular warfarin intake; failure to achieve target INR values; thrombosis of veins of any localization after LEE in dynamics. Conclusion. For the first time in Russia, modifiable and non-modifiable predictors of residual PH after PEA in patients with CTEPH were identified. An optimization algorithm for early diagnosis and treatment of CTEPH was proposed.

  • Open Access

    Therapies of chronic thromboembolic pulmonary hypertension: A review

    by Oksana Vasiltseva, Alexander Edemskiy, Devran Zeinalov, Elena Kliver, Wladimir Ussov, Denis Grankin, Dmitry Sirota, Aleksandr Chernyavskiy

    The article addresses therapies for chronic thromboembolic pulmonary hypertension (CTEPH). The main challenges of patient management at various stages of diagnosis and treatment and the prevalence and pathogenesis of CTEPH are described. Immediate and long-term outcomes after treatment are evaluated. The study aims to present current therapies for CTEPH.


  • Open Access

    Chronic thromboembolic pulmonary hypertension in an obese patient with type 2 diabetes mellitus

    by E. N. Kliver, O. Vasiltseva, A. G. Edemskiy, D. S. Grankin, D. F. Zeinalov, A. M. Cherniavsky, О. Я. Васильцева

    Metabolic disorders represent a serious medical and social problem and are risk factors for the development of thromboembolic complications. Disturbances of both carbohydrate and fat metabolism contribute to an increase in blood viscosity, creating prothrombotic conditions, which are not always objectively assessed even by specialists. In addition, multiple comorbid conditions usually significantly complicate the prognosis. The article presents a clinical case of recurrent thrombosis of the right atrium and the orifices of the superior and inferior vena cava in a 39-year-old patient with type 2 diabetes mellitus, obesity, arterial hypertension, and varicose vein disease.